naringenin has been researched along with luteolin in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.78) | 18.7374 |
1990's | 7 (9.72) | 18.2507 |
2000's | 19 (26.39) | 29.6817 |
2010's | 39 (54.17) | 24.3611 |
2020's | 5 (6.94) | 2.80 |
Authors | Studies |
---|---|
Chang, CJ; Geahlen, RL | 1 |
Chen, K; Cheng, YC; Hu, CQ; Kilkuskie, RE; Lee, KH; Shi, Q | 1 |
Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
Habtemariam, S | 1 |
Calomme, M; Cimanga, K; Cos, P; Hu, JP; Pieters, L; Van Poel, B; Vanden Berghe, D; Vlietinck, AJ; Ying, L | 1 |
Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M | 1 |
Broedel, SE; Cihlar, RL; ElSohly, HN; Ferreira, D; Jacob, MR; Joshi, AS; Khan, IA; Khan, SI; Li, XC; Raulli, RE; Walker, LA; Zhang, Z | 1 |
Morris, ME; Yang, X; Zhang, S | 1 |
Asada, S; Imai, Y; Sugimoto, Y; Tsukahara, S | 1 |
Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
Brun, R; Lack, G; Perozzo, R; Rüedi, P; Scapozza, L; Tasdemir, D | 1 |
Domina, NG; Khlebnikov, AI; Kirpotina, LN; Quinn, MT; Schepetkin, IA | 1 |
Saeki, K; Sunaga, S; Takahashi, S; Takasawa, R; Tanuma, S; Yoshimori, A | 1 |
Chou, CJ; Frei, N; Grigorov, M; Lo Piparo, E; Scheib, H; Williamson, G | 1 |
Du, GH; Lee, SM; Liu, AL; Wang, HD; Wang, YT | 1 |
Akamatsu, M; Hosoda, A; Hotta, Y; Ishimoto, Y; Nishizaki, Y; Tamura, H; Yoshikawa, H | 1 |
Curtis-Long, MJ; Kim, JY; Lee, JW; Lee, WS; Park, KH; Ryu, HW; Ryu, YB | 1 |
Amić, D; Lucić, B | 1 |
Matsuda, H; Nakamura, S; Nakashima, S; Oda, Y; Xu, F; Yoshikawa, M | 1 |
Ataide Martins, JP; Borges de Melo, E; Castro Ferreira, MM; Friozi, MC; Marinho Jorge, TC | 1 |
Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K | 1 |
Han, XZ; Li, X; Lou, HX; Ren, DM; Wang, SQ; Wang, XN | 1 |
Cai, S; Chu, L; Gao, F; Ji, B; Jia, G; Liu, J; Liu, Y; Wang, A; Wei, Y; Wu, W; Xie, L; Zhang, D; Zhou, F | 1 |
dos Reis, CV; Foguel, D; Lima, LM; Polikarpov, I; Trivella, DB | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Chin, YW; Han, SY; Kong, JY | 1 |
Atrahimovich, D; Khatib, S; Vaya, J | 1 |
Bücherl, D; Decker, M; Heilmann, J; Kling, B; Matysik, FM; Palatzky, P; Wegener, J | 1 |
Chen, H; Li, BW; Long, YQ; Neamati, N; Sanchez, TW; Serrao, E; Wang, H; Yang, LM; Zhang, FH; Zheng, YT | 1 |
Bilia, AR; Carta, F; Ceruso, M; Karioti, A; Supuran, CT | 1 |
Ahn, HC; Cho, SC; Choi, BY; Fei, X; Keum, YS; Kim, HJ; Lee, K; Seo, SY | 1 |
Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
Cahlikova, L; Chlebek, J; Havrankova, J; Hofman, J; Hostalkova, A; Lundova, T; Musilek, K; Novotna, E; Wsol, V; Zemanova, L | 1 |
Daikonya, A; Iijima, H; Jiang, WJ; Kitanaka, S; Nemoto, T; Noritake, R; Ohkawara, M; Takamiya, T | 1 |
Aquino, TM; Araújo-Júnior, JX; da Silva-Júnior, EF; Leoncini, GO; Rodrigues, ÉES | 1 |
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
Chakraborty, A; Chakraborty, M; Frye, SV; Gu, C; Pearce, KH; Puhl-Rubio, AC; Shears, SB; Stashko, MA; Wang, H; Wang, X | 1 |
Golonko, A; Lazny, R; Lewandowski, W; Pienkowski, T; Roszko, M; Swislocka, R | 1 |
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
Fong, J; Korobkova, EA; Maran, U; Oja, M; Rice, M; Samuels, K; Sapse, AM; Williams, AK; Wong, B | 1 |
Chauvaux, N; De Greef, J; John, M; Prinsen, E; Schell, J; Schmidt, J; Van Onckelen, H; Wieneke, U | 1 |
Bauer, WD; Caetano-Anollés, G; Crist-Estes, DK | 1 |
Lugtenberg, BJ; Okker, RJ; Spaink, HP; van Brussel, AA; Wijffelman, CA; Zaat, SA | 1 |
Ortega, T; Sánchez de Rojas, VR; Somoza, B; Villar, AM | 1 |
Breen, K; Cheng, IF | 1 |
Iwashita, K; Kobori, M; Tsushida, T; Yamaki, K | 1 |
Chan, TS; Galati, G; Moridani, MY; O'Brien, PJ | 1 |
Gairola, CG; Puppala, D; Swanson, HI | 1 |
Daniel, H; Kottra, G | 1 |
Bhutani, KK; Garg, D; Kadam, RU; Paul, AT; Roy, N | 1 |
Lou, HX; Qu, Z; Ren, DM; Shi, J; Wang, XN | 1 |
Fang, F; Huang, Z; Wang, J; Wong, CW | 1 |
Fujise, K; Hutadilok-Towatana, N; Mahabusarakam, W; Pinkaew, D; Tuansulong, KA | 1 |
Leung, LK; Li, F; Lin, SM; Ye, L | 1 |
Allred, CD; Allred, KF; Awika, JM; Geera, B; Yang, L | 1 |
Al-Jaber, NA; Awaad, AS; El-Meligy, RM; Moses, JE; Zain, ME | 1 |
Fugmann, SD; Moaddel, R; Norton, DD; Ravichandran, S; Singh, N | 1 |
Bernaert, N; De Clercq, H; De Loose, M; De Paepe, D; De Vuyst, L; Van Bockstaele, E; Van Droogenbroeck, B; Wouters, D | 1 |
Cheng, M; Meng, LJ; Yu, SF; Zhou, GX; Zhou, XD; Zou, HL | 1 |
Allred, CD; Allred, KF; Awika, JM; Dykes, L; Yang, L | 1 |
Batista, MT; Costa, G; Figueiredo, IV; González-Manzano, S; González-Paramás, A; Santos-Buelga, C | 1 |
Ango, PY; Demirtas, I; Fotso, GW; Fozing, CD; Kapche, DW; Mapitse, R; Ngadjui, BT; Yeboah, EM; Yeboah, SO | 1 |
Eichenberger, M; Fischer, D; Larsen, AB; Mortensen, UH; Naesby, M; Vanegas, KG | 1 |
De Mey, M; De Paepe, B; Maertens, J; Vanholme, B | 1 |
Abalo, R; Capasso, R; Entrialgo-Cadierno, R; Fernández, J; Lombó, F; Silván, B; Uranga, JA; Villar, CJ | 1 |
Liu, J; Ma, S; Wang, S; Wang, Y; Xiao, W; Xiao, Y; Yang, R; Zhang, L | 1 |
Goto, M; Moniruzzaman, M; Moshikur, RM; Nabila, FH; Shimul, IM | 1 |
Dong, JJ; Feng, YT; He, J; Lin, WQ; Lu, CL; Ouyang, H; Peng, ZY; Wang, JX; Xiang, YP; Xiao, ZP; Zhu, HL | 1 |
Fernandes, E; Freitas, M; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
Cabrita, EJ; Fernandes, E; Freitas, M; Marques, MM; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
Alunda, JM; Baptista, C; Behrens, B; Bifeld, E; Borsari, C; Clos, J; Cordeiro-da-Silva, A; Corral, MJ; Costantino, L; Costi, MP; Dello Iacono, L; Di Pisa, F; Eick, J; Ellinger, B; Ferrari, S; Gribbon, P; Gul, S; Henrich, S; Jiménez-Antón, MD; Keminer, O; Kohler, M; Kuzikov, M; Landi, G; Luciani, R; Mangani, S; Pellati, F; Poehner, I; Pozzi, C; Reinshagen, J; Santarem, N; Tait, A; Tejera Nevado, P; Torrado, J; Trande, M; Wade, RC; Witt, G; Wolf, M | 1 |
Kang, Y; Kim, BG; Kim, S; Lee, Y; Yoon, Y | 1 |
5 review(s) available for naringenin and luteolin
Article | Year |
---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
The medicinal chemistry of Chikungunya virus.
Topics: Animals; Antiviral Agents; Biological Products; Chemistry, Pharmaceutical; Chikungunya Fever; Chikungunya virus; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |
Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
Topics: Animals; Diet; Humans; Neoplasms; Phenols; Polyphenols; Proteasome Endopeptidase Complex; Ubiquitin | 2019 |
Antiproliferative and palliative activity of flavonoids in colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Cell Proliferation; Colorectal Neoplasms; Drug Synergism; Flavanones; Flavonoids; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Luteolin; Palliative Care; Propiophenones | 2021 |
67 other study(ies) available for naringenin and luteolin
Article | Year |
---|---|
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
Topics: Antiviral Agents; Cells, Cultured; Flavonoids; Galactosides; HIV-1; Humans; Mass Spectrometry; Medicine, Chinese Traditional; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Virus Replication; Zidovudine | 1994 |
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
Topics: Animals; Apoptosis; Drug Synergism; Flavonoids; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
Topics: Enzyme Inhibitors; Flavonoids; Free Radical Scavengers; Structure-Activity Relationship; Xanthine Oxidase | 1998 |
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid | 2002 |
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
Topics: Antifungal Agents; Candida albicans; Combretaceae; Cryptococcus neoformans; Enzyme Inhibitors; Fatty Acid Synthases; Inhibitory Concentration 50; Isoflavones; Melastomataceae; Molecular Structure; Moraceae; Paspalum; Plants, Medicinal; Saccharomyces cerevisiae; Structure-Activity Relationship; Tannins; Triterpenes | 2002 |
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Division; Chemokines, CC; Dose-Response Relationship, Drug; Drug Interactions; Flavonoids; Humans; Mitoxantrone; Neoplasm Proteins; Tumor Cells, Cultured | 2004 |
Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonoids; Genistein; Humans; K562 Cells; Neoplasm Proteins; Topotecan; Transduction, Genetic; Tritium | 2004 |
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship | 2006 |
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
Topics: Animals; Antioxidants; Drug Design; Flavonoids; Humans; Phagocytes; Phenols; Polyphenols; Quantitative Structure-Activity Relationship | 2007 |
Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects.
Topics: Animals; Biological Products; Cell Line; Cell Proliferation; Enzyme Inhibitors; Flavonoids; Humans; Hydroxylation; Ketones; Lactoylglutathione Lyase; Molecular Structure; Spodoptera; Structure-Activity Relationship | 2008 |
Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
Topics: alpha-Amylases; Catalytic Domain; Digestion; Flavones; Flavonols; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Protein Conformation; Saliva; Starch; Structure-Activity Relationship | 2008 |
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
Topics: Animals; Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; Dogs; Flavonoids; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Molecular Structure; Neuraminidase; Orthomyxoviridae; Structure-Activity Relationship | 2008 |
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
Topics: Androgen Receptor Antagonists; Androgens; Cell Line, Tumor; Flavonoids; Genes, Reporter; Humans; Receptors, Androgen; Receptors, Glucocorticoid; Structure-Activity Relationship | 2009 |
Structural characteristics of flavanones and flavones from Cudrania tricuspidata for neuraminidase inhibition.
Topics: Antiviral Agents; Binding Sites; Computer Simulation; Enzyme Inhibitors; Flavanones; Flavones; Maclura; Neuraminidase; Plant Roots; Structure-Activity Relationship | 2009 |
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics | 2010 |
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
Topics: Agaricales; Animals; Antineoplastic Agents; Brassicaceae; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Intramolecular Oxidoreductases; Melanoma, Experimental; Membrane Glycoproteins; Mice; Monophenol Monooxygenase; Oxidoreductases; Plant Extracts; RNA, Messenger; Structure-Activity Relationship; Tumor Cells, Cultured | 2010 |
Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98.
Topics: Algorithms; Antimutagenic Agents; Flavonoids; Fluorenes; Least-Squares Analysis; Models, Biological; Models, Molecular; Mutagens; Quantitative Structure-Activity Relationship; Salmonella typhimurium | 2010 |
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship | 2010 |
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
Topics: Antineoplastic Agents; Cardiotonic Agents; Cell Line; Cell Line, Tumor; Chromatography, High Pressure Liquid; Doxorubicin; Drug Screening Assays, Antitumor; Flavonoids; Humans; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2010 |
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
Topics: Antioxidants; Cell Line; Fatty Liver; Flavonoids; Humans; In Vitro Techniques; Oleic Acid; Reactive Oxygen Species; Triglycerides | 2011 |
Flavonoid interactions with human transthyretin: combined structural and thermodynamic analysis.
Topics: Amino Acid Motifs; Binding Sites; Calorimetry; Crystallography, X-Ray; Flavonoids; Humans; Models, Molecular; Mutation, Missense; Prealbumin; Protein Binding; Protein Multimerization; Thermodynamics | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.
Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavonoids; fms-Like Tyrosine Kinase 3; Humans; Luteolin; Protein Kinase Inhibitors | 2013 |
The effects and mechanism of flavonoid-rePON1 interactions. Structure-activity relationship study.
Topics: Allosteric Site; Aryldialkylphosphatase; Copper; Flavonoids; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Molecular Docking Simulation; Oxidation-Reduction; Protein Binding; Protein Conformation; Recombinant Proteins; Spectrometry, Fluorescence; Structure-Activity Relationship; Tryptophan | 2013 |
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Flavonoids; Hippocampus; Hydroxybenzoates; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxidative Stress; Quercetin | 2014 |
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
Topics: Adaptor Proteins, Signal Transducing; Antiviral Agents; Catalytic Domain; Chromones; Drug Design; Drug Discovery; Flavonoids; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Molecular Structure; Morpholines; Oncogene Proteins v-fos; Structure-Activity Relationship; Transcription Factors | 2014 |
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
Topics: Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Kinetics; Phenol; Protein Binding; Quercus; Salvia; Structure-Activity Relationship | 2015 |
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
Topics: Binding, Competitive; Drug Discovery; Humans; Isocitrate Dehydrogenase; MCF-7 Cells; Molecular Structure; Mutation; Recombinant Proteins; Structure-Activity Relationship; Xanthones | 2015 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Apigenin; Daunorubicin; Enzyme Inhibitors; Flavones; Flavonoids; HCT116 Cells; Humans; Luteolin; Molecular Conformation; Molecular Structure; Neoplasms | 2015 |
Structure-activity relationship of the inhibitory effects of flavonoids on nitric oxide production in RAW264.7 cells.
Topics: Animals; Biological Products; Dose-Response Relationship, Drug; Flavonoids; Mice; Models, Molecular; Molecular Structure; Nitric Oxide; RAW 264.7 Cells; Rhodiola; Sophora; Structure-Activity Relationship | 2017 |
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
Topics: Binding Sites; Crystallography, X-Ray; HCT116 Cells; Humans; Inositol Phosphates; Molecular Structure; Phosphotransferases (Alcohol Group Acceptor); Phosphotransferases (Phosphate Group Acceptor); Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quercetin; Structure-Activity Relationship | 2019 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |
A role of flavonoids in cytochrome c-cardiolipin interactions.
Topics: Cardiolipins; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Humans; Molecular Structure; Oxidation-Reduction; Structure-Activity Relationship | 2021 |
Stimulation of indole-3-acetic acid production in Rhizobium by flavonoids.
Topics: Chromatography, High Pressure Liquid; Flavanones; Flavonoids; Gene Expression Regulation, Bacterial; Hesperidin; Indoleacetic Acids; Isoflavones; Kinetics; Luteolin; Rhizobium | 1991 |
Chemotaxis of Rhizobium meliloti to the plant flavone luteolin requires functional nodulation genes.
Topics: Chamomile; Chemotaxis; Fabaceae; Flavanones; Flavonoids; Gene Expression Regulation; Genes, Bacterial; Kinetics; Luteolin; Oils, Volatile; Plant Extracts; Plants, Medicinal; Rhizobium; Symbiosis | 1988 |
Induction of the nodA promoter of Rhizobium leguminosarum Sym plasmid pRL1JI by plant flavanones and flavones.
Topics: Escherichia coli; Flavanones; Flavonoids; Gene Expression Regulation; Luteolin; Plasmids; Promoter Regions, Genetic; Rhizobium | 1987 |
Isolation of vasodilatory active flavonoids from the traditional remedy Satureja obovata.
Topics: Animals; Aorta; Flavanones; Flavonoids; In Vitro Techniques; Luteolin; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Phytotherapy; Plants, Medicinal; Rats; Spain; Vasodilator Agents | 1996 |
On the ability of four flavonoids, baicilein, luteolin, naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex.
Topics: Adenosine Triphosphate; Antioxidants; Flavanones; Flavonoids; In Vitro Techniques; Iron; Iron Chelating Agents; Luteolin; Oxidation-Reduction; Quercetin | 2000 |
Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells.
Topics: Animals; Apigenin; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cell Division; Chalcone; Chalcones; Flavanones; Flavonoids; Genistein; Isoflavones; Luteolin; Melanoma, Experimental; Mice; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Quercetin; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation.
Topics: Apigenin; Catalase; Electron Spin Resonance Spectroscopy; Flavanones; Flavonoids; Free Radicals; Glutathione; Horseradish Peroxidase; Hydrogen Peroxide; Luteolin; Magnetic Resonance Spectroscopy; Mass Spectrometry; Quercetin; Spectrophotometry, Ultraviolet | 2001 |
Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation.
Topics: Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Transformation, Neoplastic; Dimethyl Sulfoxide; Flavanones; Flavones; Flavonoids; Humans; Kaempferols; Liver Transplantation; Luteolin; Receptors, Aryl Hydrocarbon; Resveratrol; Smoking; Stilbenes | 2007 |
Flavonoid glycosides are not transported by the human Na+/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake.
Topics: Animals; Anthocyanins; Apigenin; Binding, Competitive; Biological Transport, Active; Dose-Response Relationship, Drug; Female; Flavanones; Flavonoids; Genistein; Glucosides; Glycosides; Humans; Isoflavones; Luteolin; Membrane Potentials; Methylglucosides; Molecular Structure; Oocytes; Peptide Transporter 1; Quercetin; RNA, Complementary; Sodium-Glucose Transporter 1; Symporters; Xenopus laevis | 2007 |
Evaluation of proinflammatory cytokine pathway inhibitors for p38 MAPK inhibitory potential.
Topics: Anti-Inflammatory Agents; Biflavonoids; Cytokines; Flavanones; Flavones; Flavonoids; Glucosides; Hydrogen Bonding; Imidazoles; Luteolin; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Pyridines; Structure-Activity Relationship | 2007 |
Simultaneous determination of nine major active compounds in Dracocephalum rupestre by HPLC.
Topics: Apigenin; Calibration; Chromatography, High Pressure Liquid; Chromones; Drug Stability; Drugs, Chinese Herbal; Flavanones; Glucosides; Luteolin; Medicine, Chinese Traditional; Molecular Structure; Plant Components, Aerial; Plant Extracts; Quality Control; Reference Standards; Reproducibility of Results; Seasons; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Temperature; Time Factors | 2008 |
Structural activity relationship of flavonoids with estrogen-related receptor gamma.
Topics: Apigenin; Flavanones; Flavonoids; Genistein; Heat-Shock Proteins; HeLa Cells; Hesperidin; Humans; Isoflavones; Luteolin; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptors, Estrogen; Structure-Activity Relationship; Transcription Factors; Transcriptional Activation | 2010 |
Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase.
Topics: Animals; Biflavonoids; Flavanones; Garcinia; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Luteolin; Mice; NADP; Recombinant Proteins | 2011 |
Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7.
Topics: Apigenin; Aromatase; Aromatase Inhibitors; Breast Neoplasms; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Enzyme Assays; Female; Flavanones; Genes, Reporter; Hesperidin; Humans; Luciferases, Firefly; Luteolin; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Transcription Factor AP-1; Transcription, Genetic | 2011 |
Sorghum phenolics demonstrate estrogenic action and induce apoptosis in nonmalignant colonocytes.
Topics: Animals; Apigenin; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colon; Epithelial Cells; Estrogen Receptor alpha; Female; Flavanones; Humans; Luteolin; Mice; Phytoestrogens; Plant Extracts; Sorghum | 2012 |
Antiulcerogenic activities of the extracts and isolated flavonoids of Euphorbia cuneata Vahl.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Apigenin; Euphorbia; Flavanones; Flavonoids; Kidney; Liver; Luteolin; Male; Plant Extracts; Rats; Rats, Wistar | 2013 |
Synthesis and characterization of a SIRT6 open tubular column: predicting deacetylation activity using frontal chromatography.
Topics: Apigenin; Binding Sites; Capillary Electrochromatography; Chromatography, Affinity; Drug Evaluation, Preclinical; Flavanones; Histone Deacetylase Inhibitors; Kaempferols; Luteolin; Magnetics; Models, Molecular; Quercetin; Sirtuins | 2013 |
Antioxidant changes of leek (Allium ampeloprasum var. porrum) during spontaneous fermentation of the white shaft and green leaves.
Topics: Allium; Antioxidants; Belgium; Coumaric Acids; Cysteine; Fermentation; Flavanones; Flavonoids; Food Preservation; Food-Processing Industry; Food, Organic; Gram-Negative Bacteria; Gram-Positive Bacteria; Industrial Waste; Kaempferols; Luteolin; Plant Leaves; Plant Stems; Salts | 2013 |
[Chemical constituents of flavonoids and their glycosides in Melastoma dodecandrum].
Topics: Apigenin; Chromatography; Chromatography, High Pressure Liquid; Dextrans; Flavanones; Flavonoids; Glycosides; Kaempferols; Luteolin; Magnoliopsida; Plants, Medicinal; Quercetin; Silica Gel | 2014 |
Enhanced action of apigenin and naringenin combination on estrogen receptor activation in non-malignant colonocytes: implications on sorghum-derived phytoestrogens.
Topics: Animals; Anticarcinogenic Agents; Apigenin; Cell Line; Cell Proliferation; Colon; Colonic Neoplasms; Drug Synergism; Estrogen Receptor Antagonists; Estrogen Receptor beta; Flavanones; Functional Food; Intestinal Mucosa; Luteolin; Mice; Osmolar Concentration; Phytoestrogens; Pigments, Biological; Plant Extracts; Seeds; Sorghum | 2015 |
Flavan hetero-dimers in the Cymbopogon citratus infusion tannin fraction and their contribution to the antioxidant activity.
Topics: Antioxidants; Apigenin; Chromatography, High Pressure Liquid; Cymbopogon; Ethnopharmacology; Flavanones; Flavonoids; Glycosides; Luteolin; Medicine, Traditional; Molecular Structure; Molecular Weight; Plant Leaves; Portugal; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tannins; Teas, Herbal | 2015 |
Thonningiiflavanonol A and thonningiiflavanonol B, two novel flavonoids, and other constituents of Ficus thonningii Blume (Moraceae).
Topics: Antioxidants; Ficus; Flavanones; Flavonoids; Gallic Acid; Genistein; Luteolin; Magnetic Resonance Spectroscopy; Molecular Structure; Oleanolic Acid; Parabens; Plant Bark; Plant Extracts; Plant Roots; Plant Stems; Quercetin; Sitosterols | 2016 |
Indirect and direct routes to C-glycosylated flavones in Saccharomyces cerevisiae.
Topics: Apigenin; Biosynthetic Pathways; Flavanones; Flavones; Glycosides; Glycosylation; Glycosyltransferases; Luteolin; Monosaccharides; Plant Proteins; Saccharomyces cerevisiae | 2018 |
Chimeric LysR-Type Transcriptional Biosensors for Customizing Ligand Specificity Profiles toward Flavonoids.
Topics: Apigenin; Biosensing Techniques; Flavanones; Flavonoids; Gene Expression Regulation, Bacterial; Luteolin; Metabolic Engineering; Transcription Factors | 2019 |
Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer.
Topics: Apoptosis; Drugs, Chinese Herbal; Flavanones; Humans; Inflammation; Luteolin; Medicine, Chinese Traditional; Network Pharmacology; Plant Extracts; Stomach Neoplasms | 2021 |
Formulation and characterization of choline oleate-based micelles for co-delivery of luteolin, naringenin, and quercetin.
Topics: Flavonoids; Luteolin; Micelles; Oleic Acid; Quercetin; Staphylococcus aureus | 2023 |
Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
Topics: Bacterial Proteins; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Helicobacter pylori; Kinetics; Models, Chemical; Models, Molecular; Molecular Conformation; Molecular Structure; Oxidation-Reduction; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship; Urease | 2013 |
Modulation of human neutrophils' oxidative burst by flavonoids.
Topics: Flavonoids; Humans; Luminescent Measurements; Molecular Structure; Neutrophils; Oxidation-Reduction | 2013 |
Inhibition of LOX by flavonoids: a structure-activity relationship study.
Topics: Dose-Response Relationship, Drug; Flavonoids; Glycine max; Humans; Leukotriene B4; Lipoxygenase; Molecular Structure; Neutrophils; Structure-Activity Relationship | 2014 |
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs.
Topics: Animals; Biological Products; Cell Line; Dose-Response Relationship, Drug; Flavonols; Humans; Macrophages; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2016 |
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Binding Sites; Flavones; Flavonoids; Flavonols; Liposomes; Molecular Docking Simulation; Phosphatidylinositol Phosphates; Pleckstrin Homology Domains; Protein Binding; Quantitative Structure-Activity Relationship | 2017 |